No Data
RNA Stock Hits Record High on Entering the Cardiac Disease Space
Avidity Biosciences: Expanding Horizons in Precision Cardiology With New Genetic Targets
Avidity Biosciences Price Target Maintained With a $65.00/Share by Chardan Capital
Avidity Biosciences Is Maintained at Buy by Chardan Capital
Avidity Biosciences Jumps 16%; Reaches All-time High
Express News | Avidity Biosciences Shares Are Trading Higher. Needham Reiterated a Buy Rating on the Stock